Sung Ho Wang, Founder and CEO Biosensors and electrochemical sensors are pivotal in modern healthcare devices. These cutting-edge technologies are the linchpin for monitoring critical biological parameters, diagnosing diseases, and elevating patient care standards.
NEMESIS is one of the drivers behind these technologies, leveraging its extensive expertise in biosensors and engineering to deliver custom semiconductor chips for digital healthcare devices.
The tailored and intelligent biosignal processing solutions offered by Nemesis are addressing the growing remote healthcare market challenges like short battery life, large form factor, high costs, and limited customization options from major chip vendors.
“We are addressing the growing demand for smaller, highly accurate sensors with multi-modality support, catering to the increasing popularity of wearable healthcare devices. The compact, portable biosensors are crucial for point-of-care diagnostics and health monitoring,” says Sung Ho Wang, founder and CEO of NEMESIS.
NEMESIS identifies clients’ objectives through in-depth consultations. Whether developing a smaller form factor to meet design requirements, extending battery life to gain a competitive edge, or navigating existing patents for easy market entry, it works collaboratively to provide finely tuned solutions.
The Mark Of Precision In Biosensor Design
In biosensor design, achieving precise sensing of vital signs and biomarkers is a complex endeavor. This process involves addressing challenges such as the body’s response to chemical materials and selecting detection methods that yield meaningful data. NEMESIS fulfills all these objectives throughout the development journey, i.e., enhancing product durability by incorporating features to control PPG lights and streamline modifications. Focusing on chip design and strict quality control guarantees excellence in every operational aspect.
Its custom-made chips align with clients’ biosensors specifications. These chips prevent competitors from replicating the technology, giving customers control over their product’s label and features. For instance, in continuous glucose monitoring systems (CGMs), users desire smaller, more discreet devices without compromising accuracy. NEMESIS caters to this demand while addressing cost concerns through compact product sizes, keeping prices affordable.
The low-power analog circuits in chips ensure extended battery life and efficient operation. Its impedance-boosting technique enhances the performance of weak signals, offering a more convenient and precise option for ECG monitoring. The use of this technique expands the range of detectable signals, leading to improved accuracy and performance. Its chips support multiple sensing modes, enabling simultaneous monitoring of various bio signals, a significant advantage for users.
Facilitating Various Applications With Customizable Biosignal Processing
Nemesis technology isn’t limited to CGMs; it extends to a range of applications, including EEG, 0ECG, EMG, and bioimpedance. With support for various sensors, its chips offer a versatile and robust solution for diverse healthcare and monitoring needs. To achieve clear (effective) noise filtration, Nemesis incorporates TinyML-based machine learning algorithms into its chips, facilitating intelligent functions without excessive power consumption or storage requirements.
We are addressing the growing demand for smaller, highly accurate sensors with multi-modality support, catering to the increasing popularity of wearable devices
These capabilities have led to numerous success stories. One of their clients in the field of in vitro diagnostics faced a significant challenge in developing compact, affordable, and energy efficient CGMs, all critical factors for success. With NEMESIS’ support, the client was able to select the right chips and sensors. Its customization for miniature chips, reduced power consumption, and integrated intelligent personalization features. This collaborative effort paved the way for their competitive CGMS in the market.
Paving The Way For The Future Of Healthcare Technology
NEMESIS, with its highly qualified team of engineers, including six PhDs and three master’s degree holders, has a rich history of innovation and success. The founders have a proven track record of successfully starting, managing, and selling a semiconductor company focused on wireless SoC. Its extensive experience is highlighted by the Korean Presidential Award it received in 2006 for founding and operating a wireless association.
With a commitment to providing innovative solutions and improving the functionality and performance of biosensor and electrochemical sensor products, NEMESIS is crucial in advancing the field of bio-signal processing and empowering companies to make informed decisions.
